<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> and non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are interrelated disorders which have been reported to occur either simultaneously or sequentially in the same patient </plain></SENT>
<SENT sid="1" pm="."><plain>We report here the development of nodular sclerosing type <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> in a patient two decades after successful treatment for Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with cyclophosphomide and abdominal resection (AR) </plain></SENT>
<SENT sid="2" pm="."><plain>While the <z:hpo ids='HP_0003674'>onset</z:hpo> of symptoms after treatment for Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was seven years definitive diagnosis of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> was only made 22 years after the initial diagnosis of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The recurrent and solitary nature ofthe <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> and the fact that it was initially reported as reactive <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> is typical of nodular lymphocyte predominant <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We believe that there was a transitory period of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> as nodular lymphocyte predominant <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> </plain></SENT>
</text></document>